XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 [Financial Post (Toronto, Ontario, Canada)]
XORTX Therapeutics Inc. (XRTX)
Company Research
Source: Financial Post
? Health consequences of chronically high uric acid and xanthine oxidase in polycystic kidney disease in rats, mice and humans ? CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the acceptance of an abstract submitted to the American Society of Nephrology (the “ASN”). The abstract entitled “Xanthine oxidase in rats, mice and humans with polycystic kidney disease” was reviewed by the ASN review panel for scientific merit and novel discoveries. The study was conducted at the University of Colorado in the independent laboratory of Dr. Charles Edelstein and was sponsored by XORTX and will be presented during the Session Title: Genetic Diseases: Cystic – Therapeutic Investigations and Prognosis. Selected results from the study include:
Show less
Read more
Impact Snapshot
Event Time:
XRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XRTX alerts
High impacting XORTX Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
XRTX
News
- XORTX Strengthens Executive Team [Yahoo! Finance]Yahoo! Finance
- XORTX Strengthens Executive TeamGlobeNewswire
- XORTX Announces Presentation at the Rare and Genetic Disease Summit [Yahoo! Finance]Yahoo! Finance
- XORTX Announces Presentation at the Rare and Genetic Disease SummitGlobeNewswire
- XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024GlobeNewswire
XRTX
Sec Filings
- 12/19/24 - Form 6-K
- 12/13/24 - Form 424B5
- 12/12/24 - Form 6-K
- XRTX's page on the SEC website